| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/23/2012 | US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 02/23/2012 | US20120045417 Methods and compositions for islet cell preservation |
| 02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display |
| 02/23/2012 | DE102010034699A1 Pyrimidinderivate Pyrimidine derivatives |
| 02/23/2012 | CA2808798A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 02/23/2012 | CA2808679A1 Novel phytochemicals from extracts of maple syrups and maple trees and uses thereof |
| 02/23/2012 | CA2808307A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 02/22/2012 | EP2420502A1 Fused pyrrolopyridine derivative |
| 02/22/2012 | EP2420501A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same |
| 02/22/2012 | EP2420496A2 Antiepileptic, hypocholesterolemic and neuroprotective compound |
| 02/22/2012 | EP2420244A1 Lipid metabolism-improving agent |
| 02/22/2012 | EP2419425A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease |
| 02/22/2012 | EP2419419A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419418A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419417A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419415A1 Compounds affecting glycemic index |
| 02/22/2012 | EP2419408A1 3-aryl or heteroaryl-substituted indole derivative |
| 02/22/2012 | EP2419114A1 Bacterial compositions for prophylaxis and treatment of degenerative disease |
| 02/22/2012 | EP2419097A1 Pharmaceutical compositions |
| 02/22/2012 | EP2419093A2 Methods of reduction of interpatient variability |
| 02/22/2012 | EP2418972A1 High fiber nutritional emulsions for blood glucose control |
| 02/22/2012 | EP2234992B1 Piperazine derivatives and their use as leptin receptor modulators |
| 02/22/2012 | EP1615655B1 Use of compositions for mucosal and oral administration comprising hcg fragments |
| 02/22/2012 | EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 02/22/2012 | CN202146448U 具有降血糖、血脂功效的茶色素胶囊 Tea pigment capsule has a hypoglycemic, lipid efficacy |
| 02/22/2012 | CN1951230B 碳酸钙粉末组合物及其制备方法 Calcium carbonate powder composition and preparation method |
| 02/22/2012 | CN1854151B 多巴胺转运蛋白拟肽抑制剂及其应用 Peptidomimetic inhibitor of dopamine transporter and its application |
| 02/22/2012 | CN102361865A 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof |
| 02/22/2012 | CN102361864A Substituted 3-benzofuranyl-indol-2-one-3-acetamididopiperazine derivatives, preparation thereof, and therapeutic use thereof |
| 02/22/2012 | CN102361857A Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 02/22/2012 | CN102361856A Modulators of cystic fibrosis transmembrane conductance regulator |
| 02/22/2012 | CN102361647A Fgf21 derivatives with albumin binder a-b-c-d-e- and their use |
| 02/22/2012 | CN102361637A Expression promoter for redox-related factor |
| 02/22/2012 | CN102358752A GLP-1 and exendin related invention |
| 02/22/2012 | CN102358741A Azepinoindole derivatives as pharmaceutical agents |
| 02/22/2012 | CN102358735A Low toxicity multiple independently target able drugs-nitrogen aromatic ring-containing CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
| 02/22/2012 | CN102358731A 2-substituted-6,7-dimethoxy tetralin isoquinoline derivative, preparation method thereof, medicinal composition and application thereof |
| 02/22/2012 | CN102358730A Micromolecular methyl ethyl ketone (MEK) protein kinase inhibitor |
| 02/22/2012 | CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/22/2012 | CN102357226A Application of Chinese herbal medicine turmeric extraction in preparation of slimming and lipid-lowering drug or drug with lipase activity inhibition effect |
| 02/22/2012 | CN102357212A Compound product obtained through supercritical CO2 extraction, and preparation method thereof |
| 02/22/2012 | CN102357209A Extraction method of bamboo shoot flavonoid and tannin |
| 02/22/2012 | CN102357208A Traditional Chinese medicine composition for treating diabetes, hyperglycemia, hypertension, and hyperlipidemia |
| 02/22/2012 | CN102357195A Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
| 02/22/2012 | CN102357174A Chinese patent drug for invigorating circulation of blood and promoting circulation of qi |
| 02/22/2012 | CN102357156A Healthcare product with lead-removing function |
| 02/22/2012 | CN102357150A Application of extractive of Chinese herbal medicine medlar to prepare weight-losing lipid-lowering medicines or medicines with effects of inhibiting lipase activity |
| 02/22/2012 | CN102357142A Use of water extract or ethanol extract of Chinese herbal medicine seville orange flower in preparation of drug for losing weight and reducing blood fat or drug for inhibiting lipase activity |
| 02/22/2012 | CN102357141A Application of Chinese herbal medicine bitter orange extract to preparation of medicament for losing weight and reducing fat or medicament with lipase activity inhabiting function |
| 02/22/2012 | CN102357138A Red sage root-panax notoginseng pill |
| 02/22/2012 | CN102357136A Application of Chinese herbal medicine papaya extract to preparation of medicament for losing weight and reducing fat or medicament with lipase activity inhabiting function |
| 02/22/2012 | CN102357131A Method for preparing astragalus polysaccharide glucose-lowering capsule |
| 02/22/2012 | CN102357128A Application of extractive of Chinese herbal medicine cortex moutan to prepare weight-losing lipid-lowering medicines or medicines with effects of inhibiting lipase activity |
| 02/22/2012 | CN102357126A Application of Chinese herbal medicine caulis polygoni multiflori extract in preparing weight-losing and lipid-lowering medicaments or in preparing medicaments with lipase activity inhibition effect |
| 02/22/2012 | CN102357120A Application of extractive of Chinese herbal medicine scutellaria baicalensis to prepare medicines with effects of inhibiting lipase activity |
| 02/22/2012 | CN102357115A Sugar-free compound wintercreeper mixture and production method thereof |
| 02/22/2012 | CN102357114A Application of Chinese herbal medicine kudzu root extracts in preparation of weight-losing lipid-lowering medicines or medicines with lipase activity inhibition effect |
| 02/22/2012 | CN102357113A Application of Chinese herbal medicine fiveleaf gynostemma in preparation of weight-reducing lipid-lowering drug or in preparation of drug with lipase activity inhibition effect |
| 02/22/2012 | CN102357110A New application of yerbadetajo |
| 02/22/2012 | CN102357109A Use of water extract or ethanol extract of Chinese herbal medicine radix cynanchi atrati in preparation of drug for losing weight and reducing blood fat or drug for inhibiting lipase activity |
| 02/22/2012 | CN102357106A Application of Chinese herbal medicine campsis grandiflora extracts in preparation of weight-losing lipid-lowering medicines or medicines with lipase activity inhibition effect |
| 02/22/2012 | CN102357098A Pharmaceutical composition, uses and preparing method thereof |
| 02/22/2012 | CN102357096A Statins zinc salt-containing blood fat-reducing composite |
| 02/22/2012 | CN102357094A Pharmaceutical composition containing eighteen amino acids |
| 02/22/2012 | CN102357088A Metformin hydrochloride enteric-coated tablet |
| 02/22/2012 | CN102357085A Stable method for preparing repaglinide compressed tablets |
| 02/22/2012 | CN102357081A Composite fat-soluble vitamin freeze-dried powder injection and preparation method thereof |
| 02/22/2012 | CN102356985A Medicinal pillow with effect of regulating blood fat |
| 02/22/2012 | CN102356837A Combined food for reducing blood sugar |
| 02/22/2012 | CN102356835A Method for microwave hydrolysis of pollen |
| 02/22/2012 | CN102100858B 一种治疗早期糖尿病肾病的中药制剂及制备方法 A Chinese medicine and its preparation method of treating early diabetic nephropathy |
| 02/22/2012 | CN102018660B 萘哌地尔栓剂及其制备方法 Naftopidil suppositories and its preparation method |
| 02/22/2012 | CN101985470B 胰高血糖素样多肽-1类似物及其制备方法与应用 Glucagon-like peptide 1 analog and preparation method and application |
| 02/22/2012 | CN101985432B 3-Fmoc胺基-3-（3-硝基-4-氟苯基）丙酸及其制备方法 3-Fmoc-3- (3-nitro-4-fluorophenyl) propionic acid and its preparation method |
| 02/22/2012 | CN101966228B 一种厚朴生物碱的用途 One kind of Magnolia officinalis alkaloid use |
| 02/22/2012 | CN101912435B 饿蚂蝗提取物及其应用 Hungry leech extract and its Applications |
| 02/22/2012 | CN101817932B 聚酰胺-胺树型高分子改性的大孔交联壳聚糖微球和制备方法 Polyamide - amine tree macroporous polymer modified crosslinked chitosan microspheres and preparation methods |
| 02/22/2012 | CN101805285B 含烟酸姜黄素酯衍生物及其制造方法和用途 Nicotinic acid ester derivatives containing curcumin and its manufacturing method and use thereof |
| 02/22/2012 | CN101574348B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method |
| 02/22/2012 | CN101492416B 影响葡糖激酶的化合物 Effect of compound of glucokinase |
| 02/22/2012 | CN101491333B 降血脂茶 Lowering tea |
| 02/22/2012 | CN101480421B 鹰嘴豆油脂在制备治疗糖尿病药物或保健食品的应用 Chickpeas fat in the preparation of the treatment of diabetes drug or health food applications |
| 02/22/2012 | CN101407557B 一种金钗石斛多糖提取物的制备和应用 A preparation and application of Dendrobium nobile polysaccharide extract |
| 02/22/2012 | CN101323613B 一种小檗碱加成物、含有该加成物的药物及其制备方法 One kind of berberine adducts, adducts containing the drug and its preparation method |
| 02/22/2012 | CN101269148B 用于预防出生缺陷并改善记忆的药物组合物 For the prevention of birth defects, and a pharmaceutical composition for improving memory |
| 02/22/2012 | CN101269128B 用于预防出生缺陷和改善记忆的药物组合物 For the prevention of birth defects and a pharmaceutical composition for improving memory |
| 02/22/2012 | CN101052316B 包含脂肪掺合物的营养品 Nutrition containing the fat blend |
| 02/21/2012 | US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
| 02/21/2012 | US8119665 Aryl imidazoles and related compounds as C5a receptor modulators |
| 02/21/2012 | US8119658 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 02/21/2012 | US8119648 Arthritis, obesity, (non-insulin dependent) diabetes calcitonin-induced osteoporosis; administering allograft transplantation; dipeptidyl peptidase-IV (DPP-IV) inhibitors |
| 02/21/2012 | US8119633 Substituted sulfonamide compounds |
| 02/21/2012 | US8119621 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| 02/21/2012 | US8119619 Pregnane steroids and their use in the treatment of CNS disorders |
| 02/21/2012 | US8119609 Apoptosis and increased production of ceramides and DAG are normalized in the presence of antioxidants |
| 02/21/2012 | US8119405 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | CA2529207C 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2487362C Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |